Implementing services for Early Infant Diagnosis (EID) of HIV: a comparative descriptive analysis of national programs in four countries

January 2011
BMC Public Health;2011, Vol. 11 Issue 1, p553
Academic Journal
The article presents a study examining when and where HIV-exposed infants and children are being diagnosed, and whether the Early Infant Diagnosis (EID) service is being maximally utilized to improve health outcomes for HIV-exposed children in four countries across Africa and Asia. The study found that a large proportion of PCR- positive infants are initiated on treatment while EID testing has expanded dramatically.


Related Articles

  • Tuberculose associada a nefrocalcinose em um lactente. Afonso, Paula; Extreia, Joana; Monteiro, Ísis; Correia, Susana // Scientia Medica;abr-jun2014, Vol. 24 Issue 2, p1 

    AIMS: To report a case of tuberculosis with unusual presentation. CASE DESCRIPTION: An eight months old infant without infection by the human immunodeficiency virus (HIV), born of an HIV-positive mother with pulmonary tuberculosis, was hospitalized for fever lasting 15 days, with no other...

  • HIV/AIDS: Where We Stand in the Fight. KASHEF, ZIBA // Ebony;Dec2014, Vol. 70 Issue 2, p69 

    The article discusses the state of research on HIV/AIDS in 2014. Developments mentioned include a baby in Mississippi who had previously been tested negative of AIDS testing positive again, the number of people newly diagnosed with HIV decreasing by 33 percent between 2002 and 2011, and a study...

  • HIV Disclosure Among HIV Positive New Mothers in South Africa. Peltzer, Karl; Mlambo, Gladys // Journal of Psychology in Africa;2013, Vol. 23 Issue 2, p327 

    The aim of this study was to determine the prevalence of HIV disclosure and associated factors in HIV-positive new mothers. A cross-sectional study was carried out on 607 systematically recruited HIV-positive new mothers in 48 primary health care clinics in Nkangala district, Northeastern South...

  • Evaluation and Management of Infants and Young Children with Fever. Luszczak, Michael // American Family Physician;10/1/2001, Vol. 64 Issue 7, p1219 

    A practice guideline for the management of febrile infants and children younger than three years of age sparked controversy when it was published in 1993. Surveys indicate that many office-based physicians do not agree with recommendations for venipuncture and bladder catheterization in nontoxic...

  • Recurrent Cyanotic Attacks due to Unilateral Upper Airway Obstruction in Infants. Singh, Amrik; Lingam, S. // Clinical Pediatrics;Aug1980, Vol. 19 Issue 8, p563 

    Two infants presented with recurrent brief cyanotic attacks and had unilateral nasal discharge. Both were poor feeders. The triad—transient cyanotic attacks, poor feeding and unilateral nasal discharge—points to unilateral upper airway obstruction. When the obstruction was...

  • Is my baby contagious? O'Callaghan, Kitty // Baby Talk;May2004, Vol. 69 Issue 4, p19 

    Discusses ways of determining if sick infants are contagious. Presence of fever; Runny nose; Length of time an infection lasts.

  • The Acquired Immunodeficiency Syndrome in Infants and Children. Ammann, Arthur J. // Annals of Internal Medicine;Nov85, Vol. 103 Issue 5, p734 

    Investigates pediatric AIDS in infants and children. Establishment of a pediatric diagnosis; Experience with pediatric cases; Conclusion.

  • Zmiany skórne u niemowlÄ…t i maÅ‚ych dzieci zakażonych parwowirusem B19 -- obserwacje wÅ‚asne. Kamer, Barbara; Rotsztejn, Helena; Małafiej, Eugeniusz; Pyziak, Konrad; Kulig, Karolina // Clinical Dermatology / Dermatologia Kliniczna;2007, Vol. 9 Issue 3, p161 

    The aim: The aim of our study was to estimate the skin changes in infants and small children with parvovirosis B19. Material and methods: 157 children aged 1-36 months were diagnosed in 2nd Department of Pedaitrics and Allergology of Polish Mother's Memorial Hospital Research Institute in Lodz,...

  • Viramune now available for use in HIV-positive children.  // AIDS Patient Care & STDs;Feb99, Vol. 13 Issue 2, p128 

    Reports on the United States Food and Drug Administration's clearing of a pediatric formulation of Viramune (nevirapine) to treat infants and children infected with HIV. Results of an AIDS Clinical Trial Group; Dosage.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics